New molecular entities/new biologics - Fuzeon - Enfuvirtide for injection

被引：0

|

作者：

不详

机构：

来源：

FORMULARY | 2003年 / 38卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：182 / +

页数：2

相关论文

共 50 条

[21] New molecular entities
不详
FORMULARY, 2005, 40 (02) : 39 - 39
[22] New molecular entities
不详
FORMULARY, 2010, 45 (02) : 41 - 41
[23] New molecular entities - Arranon - Nelarabine injection - GLAXOSMITHKLINE - New therapy approved for leukemia and lymphoma
不详
FORMULARY, 2005, 40 (11) : 366 - 366
[24] New molecular entities - Cubicin - Daptomycin for injection - CUBIST - First approval in a new class of antibiotics
不详
FORMULARY, 2003, 38 (10) : 571 - 572
[25] Trends in the Safety of New Molecular Entities and Therapeutic Biologics Approved by the FDA (1980-2014)
Seoane-Vazquez, Enrique
Rodriguez-Monguio, Rosa
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 477 - 478
[26] New molecular entities - Zyvox
不详
FORMULARY, 2000, 35 (06) : 474 - 474
[27] New molecular entities - Evoxac
不详
FORMULARY, 2000, 35 (03) : 205 - 205
[28] New Drugs and New Molecular Entities in Dermatology
Eaglstein, William H.
Corcoran, Gavin
ARCHIVES OF DERMATOLOGY, 2011, 147 (05) : 568 - 572
[29] New molecular entities - Campath
不详
FORMULARY, 2001, 36 (06) : 402 - +
[30] New molecular entities - Axert
不详
FORMULARY, 2001, 36 (06) : 402 - 402

← 1 2 3 4 5 →